Juvenile Idiopathic Arthritis: Clinical Trials

168 trials for Juvenile Idiopathic Arthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

94 completed, 34 unknown, 17 recruiting, 7 terminated. 55 Not applicable, 24 Phase 3, 16 Phase 4, 10 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable55Completed 33, Unknown 10, Recruiting 6, Not yet recruiting 2, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 324Completed 17, Terminated 3, Recruiting 2, Enrolling by invitation 1, Unknown 1
Phase 416Completed 11, Unknown 3, Active not recruiting 1, Recruiting 1
Phase 110Completed 6, Enrolling by invitation 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 28Completed 4, Recruiting 2, Enrolling by invitation 1, Unknown 1
Early Phase 12Completed 2

Follow Juvenile Idiopathic Arthritis: new trials by email Literature Review of Juvenile Idiopathic Arthritis trials Research Report on Juvenile Idiopathic Arthritis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pain-Sleep in Rheumatic Disease
Better Nights, Better Days for Youth - Rheumatic Diseases, Arthritis
Not applicableNot yet recruitingThe Hospital for Sick Children432026-09-012026-08-20
Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study.
Juvenile Idiopathic Arthritis
RecruitingShanghai Jiao Tong University School of Medicine2002026-07-012026-09-02
Validity and Reliability of the International Physical Fitness Questionnaire and the Self-Perceived Health-Related Physical Fitness Questionnaire in Children and Adolescents With JIA and FMF
Juvenile Idiopathic Arthritis, Familial Mediterranean Fever
Not yet recruitingIstanbul University - Cerrahpasa1002026-07-012026-06-01
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Etanercept Optimal dosing - Juvenile Idiopathic Arthritis, Rheumatoid Arthritis
Phase 1WithdrawnDuke University2026-07-012025-09-25
Sarcopenia and Juvenile Idiopathic Arthritis
Sarcopenia screening assessment - Juvenile Idiopathic Arthritis
Not applicableNot yet recruitingCHU de Reims2002026-06-012026-06-08
Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis, Tenosynovitis
Not yet recruitingAssiut University1062026-05-012026-04-28
Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered) - Juvenile Idiopathic Arthritis
Phase 3Enrolling by invitationUniversity of Child Health Sciences and Children's Hospital, Lahore602026-01-272026-02-04
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Secukinumab - Hidradenitis Suppurativa, Pediatric Plaque Psoriasis
RecruitingNovartis Pharmaceuticals762025-12-222026-03-05
Pain in Juvenile Arthritis
Pressure pain thresholds (measured in kilopascal), Cold pain tolerance (duration in seconds) - Juvenile Idiopathic Arthritis
Not applicableRecruitingWashington University School of Medicine1402025-09-152026-07-14
Assessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Disease Activity
complete blood count, serum albumin - Juvenile Idiopathic Arthritis
Not yet recruitingSohag University902025-07-152025-07-24
Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
Secukinumab - Juvenile Idiopathic Arthritis
WithdrawnNovartis Pharmaceuticals2025-04-302026-08-07
Feasibility of a Diet Intervention for Juvenile Arthritis
Diet intervention - Arthritis, Juvenile, Arthritis, Childhood
Not applicableRecruitingThe Hospital for Sick Children542025-04-072026-07-29
Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Mesenchymal Stem Cells, Placebo - Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE)
Phase 1 / Phase 2Enrolling by invitationNational Institute of Blood and Marrow Transplant (NIBMT), Pakistan2002025-02-012025-03-21
Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA
Physical examination, Dynamic Gait Index - Juvenile Idiopathic Arthritis, Childhood Rheumatic Disease
RecruitingIstanbul University - Cerrahpasa522025-02-012026-06-02
Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean Fever
Usability and Comparison - Juvenile Idiopathic Arthritis, Familial Mediterranean Fever
CompletedIstanbul University - Cerrahpasa2162024-12-252025-06-05
Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Methotrexate, TNF Inhibitor - Juvenile Idiopathic Arthritis
Phase 4RecruitingOslo University Hospital1502024-10-242026-10-19
Fitness Integrative Training for Pediatric Rheumatology Disorders
FIT Teens - Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus of Childhood
Not applicableCompletedChildren's Hospital Medical Center, Cincinnati102024-09-242025-08-28
M3-JIA: Making Mindfulness Matter for Children With JIA
M3 Intervention group, M3 Waitlist Group - Juvenile Idiopathic Arthritis, Children
Not applicableRecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's742024-09-122026-10-09
Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy
Complete blood count - Juvenile Idiopathic Arthritis
Not yet recruitingSohag University752024-07-152024-05-14
Core Stabilization Training in Juvenile Spondyloarthropathy
core stabilization exercises, daily physical activity program - Spondylarthritis, Spondylarthropathies
Not applicableCompletedIstanbul University - Cerrahpasa302024-07-012026-06-03

Showing 20 of 168. Sign in to see all of them.

Narrower conditions

Arthritis, Juvenile (168)  ·  Arthritis (21)  ·  Motor Activity (11)  ·  Dermatomyositis (10)  ·  Lupus Erythematosus, Systemic (10)  ·  Arthritis, Rheumatoid (9)  ·  Inflammatory Bowel Diseases (6)  ·  Rheumatic Diseases (6)  ·  Autoimmune Diseases (5)  ·  Pain (5)  ·  Scleroderma, Systemic (5)  ·  Spondylarthritis (4)  ·  Spondylitis, Ankylosing (4)  ·  Arthritis, Psoriatic (3)  ·  Fibromyalgia (3)

Broader conditions

Connective Tissue Diseases (168)  ·  Immune System Diseases (168)  ·  Skin and Connective Tissue Diseases (168)  ·  Joint Diseases (167)  ·  Musculoskeletal Diseases (167)  ·  Autoimmune Diseases (163)  ·  Rheumatic Diseases (162)  ·  Arthritis (147)  ·  Pathological Conditions, Signs and Symptoms (22)  ·  Signs and Symptoms (17)  ·  Nervous System Diseases (16)  ·  Behavior (14)  ·  Muscular Diseases (13)  ·  Neurologic Manifestations (13)  ·  Skin Diseases (13)

Interventions

tocilizumab (15)  ·  Methotrexate (9)  ·  Etanercept (5)  ·  Abatacept (3)  ·  Adalimumab (3)  ·  Steroids (3)  ·  tofacitinib (3)  ·  Anti-Inflammatory Agents, Non-Steroidal (2)  ·  Blood Cell Count (2)  ·  Exercise (2)  ·  Leflunomide (2)  ·  Surveys and Questionnaires (2)  ·  baricitinib (2)  ·  sarilumab (2)  ·  secukinumab (2)

Sponsors

Hoffmann-La Roche (13)  ·  Istanbul University - Cerrahpasa (9)  ·  The Hospital for Sick Children (9)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  University Hospital, Clermont-Ferrand (6)  ·  Assiut University (4)  ·  Pfizer (4)  ·  Sohag University (4)  ·  Bristol-Myers Squibb (3)  ·  Cairo University (3)  ·  Children's Hospital Medical Center, Cincinnati (3)  ·  Duke University (3)  ·  University of Sao Paulo General Hospital (3)  ·  University of Washington (3)  ·  AbbVie (2)

Countries

United States (37)  ·  France (33)  ·  Canada (30)  ·  Germany (23)  ·  Turkey (Türkiye) (21)  ·  United Kingdom (19)  ·  Brazil (18)  ·  Spain (18)  ·  Italy (17)  ·  Mexico (15)  ·  Russia (15)  ·  Argentina (14)  ·  Australia (12)  ·  Poland (12)  ·  Belgium (9)

Top investigators

Anna-Birgitte Aga, MD PhD (2)  ·  Britt Hedenberg Magnusson, PhD DDS (2)  ·  Laura Schanberg, MD (2)  ·  Nikolay Tzaribachev, MD (2)  ·  Ragab K Elnaggar, PhD (2)  ·  Aileen L. Pangan, MD (1)  ·  Andrew Zeft, MD (1)

Results publications

PMID 38298058, PMID 30824645, PMID 32912276, PMID 33506875, PMID 36651601, PMID 11739431, PMID 14571231, PMID 17265499, PMID 17284544, PMID 17907238, PMID 18050186, PMID 20595280, PMID 21540203, PMID 21623000, PMID 21859696, PMID 22089462, PMID 22183975, PMID 22298793, PMID 22733975, PMID 22859354, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23070991, PMID 23123020, PMID 23139240, PMID 23252525, PMID 23525305, PMID 23588937, PMID 23723319, PMID 23818263, PMID 24487484, PMID 24786928, PMID 24834925, PMID 24961747, PMID 25504861, PMID 27388672, PMID 27406936, PMID 27590668, PMID 27682341, PMID 28340203, PMID 28399931, PMID 28507219, PMID 28968874, PMID 29282090, PMID 29604189, PMID 29654485, PMID 29878100, PMID 29936438

NIH funding

2009 (3), 2015 (3), 2017 (2), 2023 (2), 2016 (1), 268200700015C-2-0-0 (1), K23AR075874 (1), P30NR016585 (1), P60AR047784 (1), R01AR049762 (1), R01AR061513 (1), R01NR012734 (1), R21NR017471 (1)